Q-Motor is utilized across various clinical trials in adults with Huntington’s disease (HD) to provide quantitative, reliable assessments of motor abilities. With gene-knockdown therapies entering the clinic, development of preventative therapies for pediatric carriers of the HD mutation seems imminent. It is currently unclear if Q-Motor is useful for tracking changes in motor abilities in pediatric HD patients or at-risk youth, as most assessments have never been administered in children. We demonstrate the feasibility of administering Q-Motor tasks in a sample of children recruited from the community, and we show that Q-Motor is sensitive to age-related changes in motor abilities.
WinderJY, RoosRAC, BurgunderJM, MarinusJ, ReilmannR. Interrater reliability of the Unified Huntington’s Disease Rating Scale-total motor score certification. Mov Disord Clin Pract. 2018;5:290–5.
4.
PaulsenJS, LangbehnDR, StoutJC, AylwardE, RossCA, NanceM, et al.Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. J Neurol Neurosurg Psychiatry. 2008;79:874–80.
5.
TabriziSJ, ReilmannR, RoosRAC, DurrA, LeavittB, OwenG, et al.Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurol. 2012;11:42–53.
6.
OrthM. Observing Huntington’s disease: The European Huntington’s Disease Network’s REGISTRY. J Neurol Neurosurg Psychiatry. 2011;82:1409–12.
7.
ReilmannR, KirstenF, QuinnL. Objective assessment of progression in Huntington s disease: A 3-year follow-up study. Neurology. 2001;57:920–4.
8.
TabriziSJ, LangbehnDR, LeavittBR, RoosRA, DurrA, CraufurdD, et al.Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurol. 2009;8:791–801.
9.
BechtelN, ScahillRI, RosasHD, AcharyaT, van den BogaardSJA, JauffretC, et al.Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 2010;75:2150–60.
10.
TabriziSJ, ScahillRI, OwenG, DurrA, LeavittBR, RoosRA, et al.Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: Analysis of 36-month observational data. Lancet Neurol. 2013;12:637–49.
11.
ReilmannR, Rouzade-DominguezML, SaftC, SüssmuthSD, PrillerJ, RosserA, et al.A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington’s disease. Mov Disord. 2015;30:427–31.
12.
ReilmannR, McGarryA, GrachevID, SavolaJM, BorowskyB, EyalE, et al.Safety and efficacy of pridopidine in patients with Huntington’s disease (PRIDE-HD): A phase 2, randomised, placebo-controlled, multicentre, dose-ranging study. Lancet Neurol. 2019;18:165–76.
13.
LeeJK, MathewsK, SchlaggarB, PerlmutterJ, PaulsenJS, EppingE, et al.Measures of growth in children at risk for Huntington disease. Neurology. 2012;79:668–74.
14.
RohrbachS, BuettnerF, PollexD, MathmannP, WeinholdL, SchubertR, et al.Quantitative examination of isometric tongue protrusion forces in children with oro-facial dysfunctions or myofunctional disorders. J Oral Rehabil. 2018;45:228–34.
15.
FietzekUM, HeinenF, BerweckS, MauteS, HufschmidtA, Schulte-MöntingJ, et al.Development of the corticospinal system and hand motor function: Central conduction times and motor performance tests. Dev Med Child Neurol. 2007;42:220–7.
16.
MemisevicH, MahmutovicI, PasalicA, BiscevicII. The effects of age and gender on finger tapping speed in preschool children. Acta Neuropsychol. 2017;15:55–62.
17.
LinQ, LuoJ, WuZ, ShenF, SunZ. Characterization of fine motor development: Dynamic analysis of children’s drawing movements. Hum Mov Sci. 2015;40:163–75.
18.
HertingMM, JohnsonC, MillsKL, VijayakumarN, DennisonM, LiuC, et al.Development of subcortical volumes across adolescence in males and females: A multisample study of longitudinal changes. Neuroimage. 2018;172:194–205.
19.
GieddJN, BlumenthalJ, JeffriesNO, CastellanosFX, LiuH, ZijdenbosA, et al.Brain development during childhood and adolescence: A longitudinal MRI study. Nat Neurosci. 1999;2:861–3.
20.
MüllerK, HömbergV. Development of speed of repetitive movements in children is determined by structural changes in corticospinal efferents. Neurosci Lett. 1992;144:57–60.
21.
GarveyMA, ZiemannU, BartkoJJ, DencklaMB, BarkerCA, WassermannEM. Cortical correlates of neuromotor development in healthy children. Clin Neurophysiol. 2003;114:1662–70.
22.
TureskyTK, OluladeOA, LuetjeMM, EdenGF. An fMRI study of finger tapping in children and adults. Hum Brain Ma. 2018;39:3203–15.
23.
KieburtzK, ReilmannR, OlanowCW. Huntington’s disease: Current and future therapeutic prospects. Mov Disord. 2018;33:1033–41.
24.
Wild EJ. Huntington’s disease: The most curable incurable brain disorder?EBioMedicine. 2016;8:3–4.
25.
SampaioC, BorowskyB, ReilmannR. Clinical trials in Huntington’s disease: Interventions in early clinical development and newer methodological approaches. Mov Disord. 2014;29:1419–28.
